Demand for qPCR instruments will increase through 2036, with GeneXpert at 31.8% of the instrument type in 2026. The market was valued at USD 1.39 billion in 2025 and is expected to be worth USD 1.99 billion by 2036, creating an incremental opportunity of USD 551.8 million between 2026 and 2036.